EGYVIR: An immunomodulatory herbal extract with potent antiviral activity against SARS-CoV-2

Due to the challenges for developing vaccines in devastating pandemic situations of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), developing and screening of novel antiviral agents are peremptorily demanded. Herein, we developed EGYVIR as a potent immunomodulatory herbal extract with...

Full description

Bibliographic Details
Main Authors: Wael H. Roshdy, Helmy A. Rashed, Ahmed Kandeil, Ahmed Mostafa, Yassmin Moatasim, Omnia Kutkat, Noura M. Abo Shama, Mokhtar R. Gomaa, Ibrahim H. El-Sayed, Nancy M. El Guindy, Amal Naguib, Ghazi Kayali, Mohamed A. Ali, Dong-Yan Jin
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2020-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7673558/?tool=EBI
_version_ 1818399896417337344
author Wael H. Roshdy
Helmy A. Rashed
Ahmed Kandeil
Ahmed Mostafa
Yassmin Moatasim
Omnia Kutkat
Noura M. Abo Shama
Mokhtar R. Gomaa
Ibrahim H. El-Sayed
Nancy M. El Guindy
Amal Naguib
Ghazi Kayali
Mohamed A. Ali
Dong-Yan Jin
author_facet Wael H. Roshdy
Helmy A. Rashed
Ahmed Kandeil
Ahmed Mostafa
Yassmin Moatasim
Omnia Kutkat
Noura M. Abo Shama
Mokhtar R. Gomaa
Ibrahim H. El-Sayed
Nancy M. El Guindy
Amal Naguib
Ghazi Kayali
Mohamed A. Ali
Dong-Yan Jin
author_sort Wael H. Roshdy
collection DOAJ
description Due to the challenges for developing vaccines in devastating pandemic situations of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), developing and screening of novel antiviral agents are peremptorily demanded. Herein, we developed EGYVIR as a potent immunomodulatory herbal extract with promising antiviral activity against SARS-CoV-2. It constitutes of a combination of black pepper extract with curcumin extract. The antiviral effect of EGYVIR extract is attributed to the two key phases of the disease in severe cases. First, the inhibition of the nuclear translocation of NF-kβ p50, attenuating the SARS-CoV-2 infection-associated cytokine storm. Additionally, the EGYVIR extract has an in vitro virucidal effect for SARS-CoV-2. The in vitro study of EGYVIR extract against SARS-CoV-2 on Huh-7 cell lines, revealed the potential role of NF-kβ/TNFα/IL-6 during the infection process. EGYVIR antagonizes the NF-kβ pathway in-silico and in-vitro studies. Consequently, it has the potential to hinder the release of IL-6 and TNFα, decreasing the production of essential cytokines storm elements.
first_indexed 2024-12-14T07:27:58Z
format Article
id doaj.art-fa63c1abc24645518e928789b3c24f1f
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-14T07:27:58Z
publishDate 2020-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-fa63c1abc24645518e928789b3c24f1f2022-12-21T23:11:27ZengPublic Library of Science (PLoS)PLoS ONE1932-62032020-01-011511EGYVIR: An immunomodulatory herbal extract with potent antiviral activity against SARS-CoV-2Wael H. RoshdyHelmy A. RashedAhmed KandeilAhmed MostafaYassmin MoatasimOmnia KutkatNoura M. Abo ShamaMokhtar R. GomaaIbrahim H. El-SayedNancy M. El GuindyAmal NaguibGhazi KayaliMohamed A. AliDong-Yan JinDue to the challenges for developing vaccines in devastating pandemic situations of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), developing and screening of novel antiviral agents are peremptorily demanded. Herein, we developed EGYVIR as a potent immunomodulatory herbal extract with promising antiviral activity against SARS-CoV-2. It constitutes of a combination of black pepper extract with curcumin extract. The antiviral effect of EGYVIR extract is attributed to the two key phases of the disease in severe cases. First, the inhibition of the nuclear translocation of NF-kβ p50, attenuating the SARS-CoV-2 infection-associated cytokine storm. Additionally, the EGYVIR extract has an in vitro virucidal effect for SARS-CoV-2. The in vitro study of EGYVIR extract against SARS-CoV-2 on Huh-7 cell lines, revealed the potential role of NF-kβ/TNFα/IL-6 during the infection process. EGYVIR antagonizes the NF-kβ pathway in-silico and in-vitro studies. Consequently, it has the potential to hinder the release of IL-6 and TNFα, decreasing the production of essential cytokines storm elements.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7673558/?tool=EBI
spellingShingle Wael H. Roshdy
Helmy A. Rashed
Ahmed Kandeil
Ahmed Mostafa
Yassmin Moatasim
Omnia Kutkat
Noura M. Abo Shama
Mokhtar R. Gomaa
Ibrahim H. El-Sayed
Nancy M. El Guindy
Amal Naguib
Ghazi Kayali
Mohamed A. Ali
Dong-Yan Jin
EGYVIR: An immunomodulatory herbal extract with potent antiviral activity against SARS-CoV-2
PLoS ONE
title EGYVIR: An immunomodulatory herbal extract with potent antiviral activity against SARS-CoV-2
title_full EGYVIR: An immunomodulatory herbal extract with potent antiviral activity against SARS-CoV-2
title_fullStr EGYVIR: An immunomodulatory herbal extract with potent antiviral activity against SARS-CoV-2
title_full_unstemmed EGYVIR: An immunomodulatory herbal extract with potent antiviral activity against SARS-CoV-2
title_short EGYVIR: An immunomodulatory herbal extract with potent antiviral activity against SARS-CoV-2
title_sort egyvir an immunomodulatory herbal extract with potent antiviral activity against sars cov 2
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7673558/?tool=EBI
work_keys_str_mv AT waelhroshdy egyviranimmunomodulatoryherbalextractwithpotentantiviralactivityagainstsarscov2
AT helmyarashed egyviranimmunomodulatoryherbalextractwithpotentantiviralactivityagainstsarscov2
AT ahmedkandeil egyviranimmunomodulatoryherbalextractwithpotentantiviralactivityagainstsarscov2
AT ahmedmostafa egyviranimmunomodulatoryherbalextractwithpotentantiviralactivityagainstsarscov2
AT yassminmoatasim egyviranimmunomodulatoryherbalextractwithpotentantiviralactivityagainstsarscov2
AT omniakutkat egyviranimmunomodulatoryherbalextractwithpotentantiviralactivityagainstsarscov2
AT nouramaboshama egyviranimmunomodulatoryherbalextractwithpotentantiviralactivityagainstsarscov2
AT mokhtarrgomaa egyviranimmunomodulatoryherbalextractwithpotentantiviralactivityagainstsarscov2
AT ibrahimhelsayed egyviranimmunomodulatoryherbalextractwithpotentantiviralactivityagainstsarscov2
AT nancymelguindy egyviranimmunomodulatoryherbalextractwithpotentantiviralactivityagainstsarscov2
AT amalnaguib egyviranimmunomodulatoryherbalextractwithpotentantiviralactivityagainstsarscov2
AT ghazikayali egyviranimmunomodulatoryherbalextractwithpotentantiviralactivityagainstsarscov2
AT mohamedaali egyviranimmunomodulatoryherbalextractwithpotentantiviralactivityagainstsarscov2
AT dongyanjin egyviranimmunomodulatoryherbalextractwithpotentantiviralactivityagainstsarscov2